Monitoring with mean kinetic temperature in GxP environments

Supplied by Vaisala Oyj on Tuesday, 14 February, 2017

Regulatory bodies in drug manufacturing and distribution have long been working together to create standards for temperature monitoring that will ensure the quality of drugs, devices and biotechnology. The mean kinetic temperature (MKT) value has been identified as a potential tool for evaluating the impact of temperature on product quality.

Download this paper to discover how to perform the calculation and some basic recommendations for its appropriate use.

DOWNLOAD
5 Pages PDF
Related White Papers

Lab monitoring innovation raises the bar for data integrity

Discover how to easily monitor multiple...

How to ensure optimum accuracy and value for money

Learn about key factors for consideration when...

Continuous environmental monitoring — compliance and best practice tips

Automated environmental monitoring systems are now a critical element in many laboratory...

Content from other channels on our network

Engineers Australia supports national engineer registration

Asahi to use recycled material for all plastic soft drink bottles

Queensland Government and CSIRO launch free R&D program for SMEs

Applications open in WA for submarine sustainment contracts

Construction begins on WA gallium project

Opinion: The growing risk of AI-driven self-diagnosis in breast health

A new national approach to clinical governance

Opinion: The debate over the government's aged care algorithm is missing the point

Commonwealth Home Support Program extended to 30 June 2029

When Connectivity Becomes Critical Care — Webinar

UTS pilot project to mitigate methane emissions

Government invests $1.5m in regional science partnerships

Desalination marine works conclude at Belmont

Zip Water releases 2025 Sustainability Report

Australia's EV fleet transition will be won or lost at the depot

  • All content Copyright © 2026 Westwick-Farrow Pty Ltd